TC BioPharm announces the grant of a European patent for the use of modified gamma delta cells for the treatment of cancer and viral indications
EDINBURGH, Scotland, 28 August 2024 /PRNewswire/ — TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP), a clinical-stage biotechnology company developing a platform for allogeneic gamma delta T…
